Abstract
Cells need to strictly control their internal milieu, a function which is performed by the plasma membrane. Selective passage of molecules across the plasma membrane is controlled by transport proteins. As the liver is the central organ for drug metabolism, hepatocytes are equipped with numerous drug transporters expressed at the plasma membrane. Drug disposition includes absorption, distribution, metabolism, and elimination of a drug and hence multiple passages of drugs and their metabolites across membranes. Consequently, understanding the exact mechanisms of drug transporters is essential both in drug development and in drug therapy. While many drug transporters are expressed in hepatocytes, and some of them are well characterized, several transporters have only recently been identified as new drug transporters. Novel powerful tools to deorphanize (drug) transporters are being applied and show promising results. Although a large set of tools are available for studying transport in vitro and in isolated cells, tools for studying transport in living organisms, including humans, are evolving now and rely predominantly on imaging techniques, e.g. positron emission tomography. Imaging is an area which, certainly in the near future, will provide important insights into "transporters at work" in vivo.
Highlights
Cells need to strictly control their internal milieu, a function which is performed by the plasma membrane
Role of drug transporters in drug disposition Mammals, including humans, have evolved an elaborate array of organs, which are interconnected by the circulatory system
Cells need to strictly control their internal milieu and this is achieved by the plasma membrane, which acts as a barrier against the external milieu
Summary
What do drug transporters really do? Nat Rev Drug Discov. 2015; 14(1): 29–44. 2. 2. Kell DB, Dobson PD, Oliver SG: Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only. 3. Kell DB, Oliver SG: How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion. 4. Patel M, Taskar KS, Zamek-Gliszczynski MJ: Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites. 5. Hillgren KM, Keppler D, Zur AA, et al.: Emerging transporters of clinical importance: an update from the International Transporter Consortium. 8. Konig J, Müller F, Fromm MF: Transporters and drug-drug interactions: important determinants of drug disposition and effects.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.